Enanta Pharmaceuticals ENTA Delivers Q1 2026 Beat EPS 045 vs 050 Expected Gen GENVR Q1 2026 Earnings Beat Revenue NA EPS 067 New Study Links LowDose Finasteride to Erectile Dysfunction Risk Potentially Affecting Prescribing Patterns Safe Pro SPAI Q1 2026 Results Miss Estimates EPS 014 vs 012